Global Bronchodilators Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 13-Dec-2022
No. of pages: 96

Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.

The report focuses on the Bronchodilators market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Bronchodilators market.

Major Players in the Bronchodilators market are:

ASMACURE

Array BioPharma

Kyowa Hakko Kirin

Atopix Therapeutics

MediciNova

F. Hoffmann-La Roche

Pearl Therapeutics

Dynavax Technologies

Nycomed Pharma

Kissei Pharmaceutical

Astellas Pharma

Mitsubishi Tanabe Pharma

Mundipharma International

CHIESI Farmaceutici

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Oxagen

ALK-Abello

Pulmagen Therapeutics

Amgen

Pharmaxis

Regeneron Pharmaceuticals

On the basis of types, the Bronchodilators market is primarily split into:

Anticholinergic bronchodilators

Adrenergic bronchodilators

Bronchodilator combinations

Methylxanthines

On the basis of applications, the market covers:

Children

Adult

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Bronchodilators Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Bronchodilators Market Overview
1.1 Product Overview and Scope of Bronchodilators Market
1.2 Bronchodilators Market Segment by Type
1.2.1 Global Bronchodilators Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Bronchodilators Market Segment by Application
1.3.1 Bronchodilators Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Bronchodilators Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Bronchodilators (2017-2029)
1.5.1 Global Bronchodilators Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Bronchodilators Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Bronchodilators Industry
1.7 Impact of Carbon Neutrality on the Bronchodilators Industry

2 Bronchodilators Market Upstream and Downstream Analysis
2.1 Bronchodilators Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Bronchodilators Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 ASMACURE
3.1.1 ASMACURE Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Bronchodilators Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Array BioPharma
3.2.1 Array BioPharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Bronchodilators Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Kyowa Hakko Kirin
3.3.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Bronchodilators Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Atopix Therapeutics
3.4.1 Atopix Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Bronchodilators Market Performance (2017-2022)
3.4.4 Business Overview
3.5 MediciNova
3.5.1 MediciNova Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Bronchodilators Market Performance (2017-2022)
3.5.4 Business Overview
3.6 F. Hoffmann-La Roche
3.6.1 F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Bronchodilators Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Pearl Therapeutics
3.7.1 Pearl Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Bronchodilators Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Dynavax Technologies
3.8.1 Dynavax Technologies Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Bronchodilators Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Nycomed Pharma
3.9.1 Nycomed Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Bronchodilators Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Kissei Pharmaceutical
3.10.1 Kissei Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Bronchodilators Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Astellas Pharma
3.11.1 Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Bronchodilators Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Mitsubishi Tanabe Pharma
3.12.1 Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Bronchodilators Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Mundipharma International
3.13.1 Mundipharma International Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Bronchodilators Market Performance (2017-2022)
3.13.4 Business Overview
3.14 CHIESI Farmaceutici
3.14.1 CHIESI Farmaceutici Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Bronchodilators Market Performance (2017-2022)
3.14.4 Business Overview
3.15 GlaxoSmithKline
3.15.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Bronchodilators Market Performance (2017-2022)
3.15.4 Business Overview
3.16 AstraZeneca
3.16.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Bronchodilators Market Performance (2017-2022)
3.16.4 Business Overview
3.17 Boehringer Ingelheim
3.17.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Bronchodilators Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Oxagen
3.18.1 Oxagen Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Bronchodilators Market Performance (2017-2022)
3.18.4 Business Overview
3.19 ALK-Abello
3.19.1 ALK-Abello Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 Bronchodilators Market Performance (2017-2022)
3.19.4 Business Overview
3.20 Pulmagen Therapeutics
3.20.1 Pulmagen Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Product Profiles, Application and Specification
3.20.3 Bronchodilators Market Performance (2017-2022)
3.20.4 Business Overview
3.21 Amgen
3.21.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Product Profiles, Application and Specification
3.21.3 Bronchodilators Market Performance (2017-2022)
3.21.4 Business Overview
3.22 Pharmaxis
3.22.1 Pharmaxis Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Product Profiles, Application and Specification
3.22.3 Bronchodilators Market Performance (2017-2022)
3.22.4 Business Overview
3.23 Regeneron Pharmaceuticals
3.23.1 Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.23.2 Product Profiles, Application and Specification
3.23.3 Bronchodilators Market Performance (2017-2022)
3.23.4 Business Overview

4 Global Bronchodilators Market Landscape by Player
4.1 Global Bronchodilators Sales and Share by Player (2017-2022)
4.2 Global Bronchodilators Revenue and Market Share by Player (2017-2022)
4.3 Global Bronchodilators Average Price by Player (2017-2022)
4.4 Global Bronchodilators Gross Margin by Player (2017-2022)
4.5 Bronchodilators Market Competitive Situation and Trends
4.5.1 Bronchodilators Market Concentration Rate
4.5.2 Bronchodilators Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Bronchodilators Sales, Revenue, Price Trend by Type
5.1 Global Bronchodilators Sales and Market Share by Type (2017-2022)
5.2 Global Bronchodilators Revenue and Market Share by Type (2017-2022)
5.3 Global Bronchodilators Price by Type (2017-2022)
5.4 Global Bronchodilators Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Bronchodilators Sales, Revenue and Growth Rate of Anticholinergic bronchodilators (2017-2022)
5.4.2 Global Bronchodilators Sales, Revenue and Growth Rate of Adrenergic bronchodilators (2017-2022)
5.4.3 Global Bronchodilators Sales, Revenue and Growth Rate of Bronchodilator combinations (2017-2022)
5.4.4 Global Bronchodilators Sales, Revenue and Growth Rate of Methylxanthines (2017-2022)

6 Global Bronchodilators Market Analysis by Application
6.1 Global Bronchodilators Consumption and Market Share by Application (2017-2022)
6.2 Global Bronchodilators Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Bronchodilators Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Bronchodilators Consumption and Growth Rate of Children (2017-2022)
6.3.2 Global Bronchodilators Consumption and Growth Rate of Adult (2017-2022)

7 Global Bronchodilators Sales and Revenue Region Wise (2017-2022)
7.1 Global Bronchodilators Sales and Market Share, Region Wise (2017-2022)
7.2 Global Bronchodilators Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Bronchodilators Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Bronchodilators Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Bronchodilators Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Bronchodilators Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Bronchodilators Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Bronchodilators Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Bronchodilators Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Bronchodilators Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Bronchodilators Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Bronchodilators Market Forecast (2022-2029)
8.1 Global Bronchodilators Sales, Revenue Forecast (2022-2029)
8.1.1 Global Bronchodilators Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Bronchodilators Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Bronchodilators Price and Trend Forecast (2022-2029)
8.2 Global Bronchodilators Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Bronchodilators Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Bronchodilators Sales and Revenue Forecast (2022-2029)
8.2.3 China Bronchodilators Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Bronchodilators Sales and Revenue Forecast (2022-2029)
8.2.5 India Bronchodilators Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Bronchodilators Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Bronchodilators Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Bronchodilators Sales and Revenue Forecast (2022-2029)
8.3 Global Bronchodilators Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Bronchodilators Revenue and Growth Rate of Anticholinergic bronchodilators (2022-2029)
8.3.2 Global Bronchodilators Revenue and Growth Rate of Adrenergic bronchodilators (2022-2029)
8.3.3 Global Bronchodilators Revenue and Growth Rate of Bronchodilator combinations (2022-2029)
8.3.4 Global Bronchodilators Revenue and Growth Rate of Methylxanthines (2022-2029)
8.4 Global Bronchodilators Consumption Forecast by Application (2022-2029)
8.4.1 Global Bronchodilators Consumption Value and Growth Rate of Children (2022-2029)
8.4.2 Global Bronchodilators Consumption Value and Growth Rate of Adult (2022-2029)
8.5 Bronchodilators Market Forecast Under COVID-19

9 Industry Outlook
9.1 Bronchodilators Market Drivers Analysis
9.2 Bronchodilators Market Restraints and Challenges
9.3 Bronchodilators Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Bronchodilators Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Bronchodilators Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Bronchodilators Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Montelukast Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Montelukast Sodium market size was valued at US$ 336.3 million in 2023. With growing demand in downstream market, the Montelukast Sodium is forecast to a readjusted size of US$ 815.4 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Montelukast Sodium market. Montelukast Sodium are expected to show stable growth in the future market. However, product d......
  • Global Montelukast Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Montelukast Sodium market size was valued at USD 353.8 million in 2023 and is forecast to a readjusted size of USD 803.8 million by 2030 with a CAGR of 12.4% during review period. Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chr......
  • Asthma Therapeutics - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 114
    The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Asthma Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 2680 Onwards        Pages: 163
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Budesonide Aerosol Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 146
    Report Overview: The Global Budesonide Aerosol Market Size was estimated at USD 7996.70 million in 2022 and is projected to reach USD 41912.84 million by 2029, exhibiting a CAGR of 26.70% during the forecast period. This report provides a deep insight into the global Budesonide Aerosol market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key marke......
  • Global Asthma Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 3280 Onwards        Pages: 139
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Montelukast Sodium Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 144
    Report Overview: Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis. The Global Montelukast Sodium Market Size was estimated at USD 816.70 million in 2022 and is projected to reach USD 1921.37 million by 20......
  • Global Doxofylline (API) Market Research Report 2023
    Published: 28-Nov-2023        Price: US 2900 Onwards        Pages: 88
    Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in The treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. According to QYResearch's new survey, global Doxofylline (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with The CAGR of % during The period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Uk......
  • Global Montelukast Sodium Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 164
    Montelukast sodium is an organic sodium salt. Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs